Literature DB >> 31278171

Vitamin D for secondary prevention of acute wheeze attacks in preschool and school-age children.

Christos Stefanidis1,2, Adrian R Martineau3,2, Chinedu Nwokoro3, Christopher J Griffiths3,2, Andrew Bush3,4.   

Abstract

INTRODUCTION: Vitamin D is best known for its role in bone health; however, the discovery of the vitamin D receptor and the expression of the gene encoding the vitamin D 1α-hydroxylase (CYP27B1) enzyme in a wide variety of tissues including immune cells and respiratory epithelium has led to the discovery of potential roles for vitamin D in the prevention of acute wheeze.
METHODS: We review here the literature concerning the relationships between circulating 25-hydroxyvitamin D (25(OH)D) concentration and secondary prevention of acute wheeze attacks in preschool and school-age children.
RESULTS: Epidemiological data suggest that vitamin D insufficiency (25(OH)D <75 nmol/L) is highly prevalent in preschool and school-age children with wheeze. Preschool age children with a history of wheeze attacks and circulating 25(OH)D <75 nmol/L are at increased risk and frequency of future acute wheeze. However, no consistent association between low vitamin D status and risk of acute wheeze is reported in school-age children. Seven randomised controlled trials (RCTs) with relatively small sample sizes (30-430) and variable quality showed inconsistent results regarding the effect of oral vitamin D supplementation during childhood on the risk of asthma attacks, asthma symptom control, inhaled corticosteroid requirements, spirometry and unscheduled healthcare attendances for wheeze. A RCT showed that vitamin D supplementation had no effect on the frequency of unplanned healthcare attendances due to acute wheeze in 22 preschool children. DISCUSSION: An evidence-based recommendation for the use of vitamin D as a preventive therapy for wheeze attacks cannot be made until results of further trials are available. The assessment of circulating 25(OH)D concentration and the optimisation of vitamin D status to prevent acute respiratory tract infections, and to maintain skeletal and general health in preschool and school-age children with acute wheeze is worthwhile in its own right, but whether this will reduce the risk of acute wheeze attacks is unclear. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  25-hydroxyvitamin D; acute wheeze secondary prevention; children; vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31278171     DOI: 10.1136/thoraxjnl-2019-213278

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.

Authors:  Erick Forno; Leonard B Bacharier; Wanda Phipatanakul; Theresa W Guilbert; Michael D Cabana; Kristie Ross; Ronina Covar; James E Gern; Franziska J Rosser; Joshua Blatter; Sandy Durrani; Yueh-Ying Han; Stephen R Wisniewski; Juan C Celedón
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

2.  Vitamin D replacement in children with acute wheeze: a dose-escalation study.

Authors:  Christos Stefanidis; Andrew Bush; Christopher Newby; Chinedu Nwokoro; Susan Liebeschuetz; Imogen P Skene; Christopher J Griffiths; Adrian R Martineau
Journal:  ERJ Open Res       Date:  2022-05-16

3.  Can vitamin D3 supplementation reduce the time to severe asthma exacerbations in children with asthma?

Authors:  Idan Bokobza; Nour El Hadi; Andrew Bush; Heidi Makrinioti
Journal:  Breathe (Sheff)       Date:  2021-09

4.  Serum ionised calcium and the risk of acute respiratory failure in hospitalised patients: a single-centre cohort study in the USA.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Api Chewcharat; Michael A Mao; Kianoush B Kashani
Journal:  BMJ Open       Date:  2020-03-23       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.